HALDOL SOLUTAB Drug Patent Profile
✉ Email this page to a colleague
When do Haldol Solutab patents expire, and when can generic versions of Haldol Solutab launch?
Haldol Solutab is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in HALDOL SOLUTAB is haloperidol. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Haldol Solutab
A generic version of HALDOL SOLUTAB was approved as haloperidol by MYLAN on June 10th, 1986.
Summary for HALDOL SOLUTAB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Patent Applications: | 1,743 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HALDOL SOLUTAB at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HALDOL SOLUTAB
US Patents and Regulatory Information for HALDOL SOLUTAB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | HALDOL SOLUTAB | haloperidol | TABLET;ORAL | 017079-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |